• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Therapy Areas
  • Gastrointestinal
  • A cross-sectional study on the prevalence of GERD in primary care patients with upper GI symptoms using the GERD-Q. The Bulgarian GERD-Q Study.

Disease
acid reflux
Drug Name
Nexium
Generic Name
esomeprazole
Sponsor
AstraZeneca
Drug Status
Approved Medicine
Phase
Non-Interventional Study
Start Date
Nov 11, 2009
Study Name
NIS-GBG-NEX-2009/1
Study Id
NIS-GBG-NEX-2009/1
ClinicalTrials.gov ID
NCT01020890
Recruiting Status
Closed
Protocol Status
Not Available
Report
Jan 7, 2011
  • NIS-GBG-NEX-2009_1.pdf (202 KB)

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013